-
Product Insights
Therapeutic Drug Monitoring Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Therapeutic Drug Monitoring Pipeline Market Report Overview Therapeutic drug monitoring tests include reagents and test kits intended to measure different types of therapeutic drugs from samples ranging from serum/blood, urine, hair and sweat. The therapeutic drug monitoring pipeline market research report provides comprehensive information about the Therapeutic drug monitoring pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Key Segments ·      Immunosuppressant Therapeutic Drug Monitoring...
-
Product Insights
Acquired Gene or Chromosome Alterations Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Acquired Gene or Chromosome Alterations comprise of reagents employed for genetic testing to detect cancer-causing/ related alterations, such as k-ras. It is used to detect BRCA 1+2, Telomerase, and HER-2/neu (human epidermal growth factor receptor 2) also. The Acquired Gene pipeline market research report provides comprehensive information about the Acquired Gene pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Product Insights
Clinical Chemistry Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
The clinical chemistry segment comprises reagents, test kits, and electrodes. This aid in determining the concentration or activity of biomolecules, such as proteins, carbohydrates, lipids, enzymes, minerals, or other small molecules. These biomolecules could be easily collected via body fluids such as blood, serum or plasma, and urine. The clinical chemistry pipeline market research report provides comprehensive information about the clinical chemistry pipeline products with a comparative analysis of the products at various stages of development and information about the...
-
Product Insights
Clinical Decision Support Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
The Clinical Decision Support Systems pipeline market research report provides comprehensive information about the Clinical Decision Support Systems pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Sector Analysis
Next Generation Sequencing (NGS) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Next generation sequencing (NGS) refers to high-throughput methods for DNA sequencing that are not Sanger-based. NGS technology has largely superseded Sanger sequencing in academic or genome research and is increasingly being applied in clinical practice. The technique is highly scalable and typically involves fragmenting the genome and then randomly sampling for and sequencing these fragments. NGS can be performed on formalin-fixed and paraffin-embedded (FFPE) and freshly collected tissue specimens and on fine-needle aspiration samples and small biopsy specimens. The Next...
-
Product Insights
Parkinson’s Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Parkinson's disease (PD) is a neurodegenerative disorder characterized by movement dysfunctions. The main finding in brains of people with PD is loss of dopaminergic neurons in substantia nigra. Symptoms generally develop slowly over years. People with PD experience dyskinesia, dystonia, tremor, stiffness and impaired locomotory functions. Risk factors include age, genetic factors, environmental factors and gender. Treatment options include anticholinergics, COMT inhibitors and dopamine agonists. The Parkinson’s disease pipeline drugs market research report provides comprehensive information on the therapeutics under...
-
Product Insights
Rett Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rett Syndrome – Drugs In Development, 2022, provides an overview of the Rett Syndrome (Central Nervous System) pipeline landscape. Rett syndrome is a neurodevelopmental disorder. This is caused by genetic mutation on MECP2 gene. Rett syndrome is described in four stages: Stage I or early onset, Stage II or rapid destruction, Stage III, or the plateau and Stage IV, or the late motor deterioration stage. Symptoms include slowed growth, loss...